PHOTO
Jeddah: Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has teamed with the Ministry of Health (MOH) in Saudi Arabia to provide a first of its kind integrated Cardiovascular Information System (CVIS) across multiple facilities throughout the Kingdom of Saudi Arabia. Patient medical information will be available on demand at the point of care in each one of the connected hospitals to help improve quality access to cardiology care managed by a network of specialists. The Philips CVIS includes advanced software technology and image analysis to simplify cardiovascular data management for cardiology departments to work more efficiently and accurately.
According to the World Health Organization, cardiovascular diseases (CVDs) are the number 1 cause of death globally [1].They are also highly prevalent in Kingdom of Saudi Arabia [2]. Cardiology is also one of the most complex areas of the hospital enterprise, with large quantities of data generated by various caregivers across multiple locations along the care pathway. By integrating disparate cardiology systems in the public MOH cardiac centers around the kingdom, the Philips CVIS can help reduce data entry, simplify access to test results generated in other departments, and make it easier, to acquire, analyze and share patient data. The cardiology patient data information will be powered by Philips IntelliSpace Cardiovascular platform, featuring advanced archiving from the Philips Universal Data Manager (UDM) and advanced visualization from Philips IntelliSpace Portal. Seamless data sharing and connectivity between the hospitals will be managed by Philips Forcare, delivering Information health exchange (IHE) interoperability.
“With a dedicated Healthcare IT Clinical Informatics team and leadership in connected care, Philips brings a wealth of experience into the Cardiology program of the MOH,” said Ozlem Fidanci, Market Leader Middle East & Turkey at Philips. “This collaboration named as Project Taji, marks a significant step by the Ministry of Health towards Saudi vision 2030 and the elevation of cardiology services across the Kingdom of Saudi Arabia.”
Taji Project will be implemented in the cities of Mecca, Jeddah, Al Hafouf, Qaseem, Jizan, Najran, Dammam and Arar. All these cities will be connected to the Ministry of Health in Riyadh to utilize Tele-Cardiology Services among MOH Cardiac Centers. “The primary use of telecardiology is to support primary care practitioners in the area of correct diagnosis, thus empowering them to manage cardiac patients with increased confidence. It also improves the clinical training of the average practitioner, by increasing the clinician’s level of knowledge at primary level. This will equip GPs to offer better care and improve the overall healthcare system.” Said Dr. Ahmed Balkhair, Advisor to the Vice Minister and the General Supervisor of e-health Programs and IT.
“The MOH Tele-cardiology initiative helps build up an integrated Cardiovascular Information System (CVIS), Cardiac Picture Archiving and Communications System (CPACS), and an ECG Data Management System. All of which will enhance the efficiency of the Cardiology workflow for the Cardiologists and all users, and access to patient studies by authorized users from anywhere inside or outside of the network.” Said Dr. Mohammed K. Abdulaali, Assistant Deputy Minister for Hospital Affairs.
Seamless integrated cardiovascular informatics experience
Philips IntelliSpace Cardiovascular supports seamless integration with the full Philips Cardiovascular Informatics portfolio including TOMTEC, Xper IM, IntelliSpace Portal and IntelliSpace ECG. In supporting Philips' commitment to interoperability and open systems, IntelliSpace Cardiovascular also interfaces with multiple third-party applications, including scheduling systems, lab applications, and specialty PACS. This comprehensive insight helps reduce the time and frustration related to accessing multiple systems and allows clinicians to search for specific information – like previous test results – across systems in a single workspace. By aggregating all of this data, clinicians are able to make more informed decisions and better collaborate with peers, while having a seamlessly integrated experience.
Philips cardiovascular IT innovations
Philips is widely recognized as a worldwide leader in cardiovascular healthcare technology demonstrated by its innovations in diagnosis including the next generation image guided therapy platform Azurion, advances in cardiology informatics, and the development of echo navigator, which fuses live X-ray and Live echo imaging. Philips began its Cardiovascular journey in the Kingdom of Saudi Arabia as an early innovator bringing cardiovascular information systems to Riyadh in 1999. Since then, Philips Cardiovascular IT footprint has grown with a market share of over 65%.
For more information on Philips IntelliSpace Cardiovascular image and information management system, and Philips suite of cardiovascular solutions, visit [insert link to Cardiology Landing Page].
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter
Abdullah Inayat |
Co-Founder & Director |
W7Worldwide
T: +966 12 661 4579 |
M: +966 55 599 0258
E: a.inayat@w7worldwide.com|
W: www.w7worldwide.com
L: Level 6, Office 145 |
Al-Fyisaliah Business building |
P.O. Box 2064, 23442 | Jeddah KSA
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
